Importantly, it seems that the modulatory action of the acetylated androstano-arylpyrimidines on the function of ABC transporters does not depend on the type of multidrug resistance, both acquired, and inherently resistant cancer cells can be manipulated using this compound group. This evidence concerns the gene ABCG2 and cancer.